Please check your internet connection and try again.
# Magnesium Sulphate
## Overview
Magnesium sulfate is an essential mineral and electrolyte. It plays a crucial role in numerous biochemical reactions, including muscle and nerve function, blood glucose control, and blood pressure regulation.
## Primary Indications
* Treatment of hypomagnesemia.
* Management of seizures in pre-eclampsia and eclampsia.
* Treatment of torsades de pointes.
* Management of status asthmaticus (adjunctive therapy).
## Adult Dosing
* **Hypomagnesemia:**
* **Severe/Symptomatic:** 4-6 grams IV initially, followed by 1-2 grams/hour as a continuous infusion. Maintenance doses depend on serum magnesium levels and renal function. Dosing is often guided by local protocols and serum magnesium levels.
* **Mild/Asymptomatic:** 1 gram IV or IM every 6 hours for 4 doses, or 2-4 grams IM in divided doses.
* **Pre-eclampsia/Eclampsia:** Typically 4-6 grams IV loading dose, followed by 1-2 grams/hour continuous infusion. Specific regimens can vary by institution.
* **Torsades de Pointes:** 1-2 grams IV in 10-20 mL D5W or NS over 5-10 minutes. May repeat every 5-15 minutes. Continuous infusion of 0.5-1 gram/hour may be used for refractory cases.
* **Status Asthmaticus (adjunctive):** 2 grams IV diluted in 50 mL NS infused over 15-20 minutes.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and often based on weight and indication, requiring careful calculation and monitoring. Local protocols and specialist consultation are often necessary.
* **Hypomagnesemia:** Typically 25-50 mg/kg/dose IV over 5-15 minutes, not to exceed 2 grams. Repeat every 4-6 hours as needed. For continuous infusion, 10-20 mg/kg/hour.
* **Status Asthmaticus (adjunctive):** 25-40 mg/kg IV, maximum 2 grams, infused over 15-20 minutes.
## Dose Adjustments
Dose reduction is necessary in patients with impaired renal function. Monitor serum creatinine and magnesium levels closely. If CrCl is < 30 mL/min, administer with caution and reduce dose significantly. Dialysis may be required.
## Contraindications
* Hypermagnesemia.
* Heart block (unless a temporary pacemaker is in place).
* Myocardial infarction.
* Shock.
* Severe renal impairment.
## Adverse Effects
Common: Flushing, diaphoresis, hypotension, nausea, vomiting, lethargy, decreased reflexes.
Serious: Respiratory depression, cardiac arrhythmias, cardiac arrest, hypocalcemia, hyperkalemia, loss of deep tendon reflexes, muscle weakness.
## Key Drug Interactions
* **Calcium Salts:** May antagonize the effects of magnesium.
* **Neuromuscular Blocking Agents:** May potentiate neuromuscular blockade.
* **Nifedipine:** Increased risk of hypotension and muscle weakness.
* **Tetracyclines and Fluoroquinolones:** Magnesium can decrease the absorption of these antibiotics; administer at least 2 hours before or 4-6 hours after magnesium.
## Monitoring
* **Serum Magnesium Levels:** Essential for dose titration and assessing efficacy/toxicity. Target levels vary by indication.
* **Renal Function:** Serum creatinine.
* **Vital Signs:** Blood pressure, heart rate, respiratory rate.
* **Neurological Status:** Deep tendon reflexes, mental status.
* **Urine Output:** To assess renal function.
* **EKG:** Especially in torsades de pointes treatment or for suspected toxicity.
* **Serum Calcium and Potassium:** Magnesium can affect these electrolyte levels.
## Clinical Pearls
* Magnesium sulfate is administered as an IV or IM injection. IV administration is preferred for rapid correction. IM injections can be painful and should be given in divided doses in different sites if larger volumes are needed.
* Always dilute magnesium sulfate for IV infusion.
* Monitor for signs of magnesium toxicity, especially respiratory depression and loss of reflexes. Have calcium gluconate readily available as an antidote.
* In pre-eclampsia/eclampsia, magnesium sulfate is used to prevent or treat seizures, not to lower blood pressure.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information, institutional protocols, and relevant literature before making any treatment decisions.*